Back to search
FDAFDA · Food and drugs·Recall number D-0633-2018

Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15

Published April 25, 2018 · Recall initiated: March 30, 2018

Summary

FDA records drug Class II recall D-0633-2018, published April 25, 2018 and initiated March 30, 2018. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 2135 cartons; Lot: Lot: 16719 Exp. 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if AMANTADINE HCL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMANTADINE HCL
Manufacturer
AVKARE Inc.
Distributor
Nationwide
Lot
Lot: 16719 Exp. 07/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amantadine HCl Capsules, USP, 100 mg, 50 Capsules (5x10) Unite Dose, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-069-15 recalled?

Yes. FDA published recall D-0633-2018 on April 25, 2018. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMANTADINE HCL.